查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1563085

蝦疾病診斷市場：全球產業分析、規模、佔有率、成長、趨勢、2024-2033年預測

Shrimp Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 215 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球蝦疾病診斷市場的綜合報告，深入分析了關鍵市場動態，包括市場驅動因素、趨勢、機會和挑戰。這份詳細的報告揭示了預測期內的市場結構和成長潛力。

主要見解

  • 蝦疾病診斷市場規模（2024年）：5.009億美元
  • 預估市場規模（2033年）：8.21億美元
  • 全球市場成長率（2024-2033年年複合成長率）：5.6%

蝦疾病診斷市場-調查範圍

蝦疾病診斷市場致力於影響蝦子的各種疾病診斷測試的開發和應用，這對水產養殖非常重要。這個市場包括各種診斷方法，例如分子診斷、免疫診斷和生化測試。主要成長動力包括全球對蝦需求的增加、水產養殖活動的增加以及可持續蝦養殖的需求。

市場驅動因素：

有幾個關鍵因素推動全球蝦疾病診斷市場的成長。在消費和出口增加的推動下，全球對蝦的需求不斷增加是一個主要因素。此外，維持蝦群健康以確保水產養殖的生產力和盈利能力的需求推動診斷解決方案的採用。蝦農疾病控制和預防意識的提高也支持了市場的成長。

市場限制因素：

儘管存在成長潛力，但蝦疾病診斷市場仍面臨一些挑戰。先進診斷技術的高成本可能會限制其採用，特別是在小規模農民中。此外，缺乏標準化測試協議和對可用診斷解決方案的認識不足可能會阻礙市場擴張。監管挑戰和蝦疾病流行的區域差異也可能是主要障礙。

市場機會：

蝦疾病診斷市場提供了巨大的成長機會，特別是由於技術的進步。分子診斷的創新，例如基於 PCR 的檢測，預計將提高檢測疾病的能力。診斷公司和水產養殖利益相關者之間的合作可以促進創新並擴大市場範圍。此外，增加研發投資以開發具有成本效益且易於使用的診斷工具進一步擴大了成長機會。

本報告涵蓋的主要問題

  • 推動全球蝦疾病診斷市場的關鍵因素是什麼？
  • 哪些地區採用蝦疾病診斷最多？
  • 診斷技術的進步如何影響競爭格局？
  • 誰是蝦疾病診斷市場的主要參與者？ 他們採取了哪些策略來維持其市場地位？
  • 全球蝦疾病診斷市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 市場創新/發展趨勢

第4章 關鍵成功因素

  • 產品採用率分析
  • 最近的產品核准
  • 監理狀況
  • 兌換場景
  • 供應鏈分析
  • 波特的分析
  • PESTLE分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第6章 COVID-19 危機分析

  • 新冠肺炎（COVID-19）與影響分析
    • 試劑盒
    • 依疾病分類
    • 依最終用戶
    • 依國家/地區
  • 2024年市場情景

第7章 全球市場需求（金額或規模，百萬美元）分析

  • 2019-2023年過去的市值（百萬美元）分析
  • 依市場分類的2024-2033年當前和未來市場規模分析和預測（百萬美元）
    • 年成長趨勢分析
    • 絕對的獲利機會

第8章 依試劑盒的世界市場分析

  • 簡介/主要調查結果
  • 2019-2023年依試劑盒的市場規模（百萬美元）實績分析
  • 2024-2033年依試劑盒的當前和未來市場規模（百萬美元）分析和預測
    • 快速檢測試劑盒
    • 基於檢測的試劑盒
  • 試劑盒市場吸引力分析

第9章 依疾病的世界市場分析

  • 簡介/主要調查結果
  • 2019-2023年依疾病的市場規模（百萬美元）實績分析
  • 2024-2033年依疾病的當前和未來市場規模（百萬美元）分析和預測
    • WSSV（白斑症病毒）
    • TSV（Taura症候群病毒）
    • YHV/GAV（黃頭/鰓相關病毒）
    • IHHNV（傳染性皮下組織與造血病毒）
    • HPV（對蝦肝胰腺細小病毒）
    • MBV（草蝦桿狀病毒）
    • IMNV（傳染性肌肉壞死病毒）
    • NHP-B（壞死性肝胰臟炎菌）
    • MoV（Mourilyan 病毒）
    • 早期死亡症候群（EMS）
  • 依疾病分析市場吸引力

第10章 依最終用戶的全球市場分析

  • 簡介/主要調查結果
  • 2019-2023年市場規模（百萬美元）的過去分析，依最終用戶
  • 2024-2033年當前和未來市場規模（百萬美元）的分析和預測，依最終用戶
    • 漁業
    • 水產養殖研究所
    • 海洋研究所
    • 教育與研究機構
    • 其他
  • 依最終用戶的市場吸引力分析

第11章 依地區的世界市場分析

  • 簡介/主要調查結果
  • 2019-2023年過去市場規模（百萬美元）分析，依地區
  • 2024-2033年當前和未來市場規模（百萬美元）分析和預測，依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東、非洲
  • 依地區市場吸引力分析

第12章 北美市場分析

第13章 拉丁美洲市場分析

第14章 歐洲市場分析

第15章 東亞市場分析

第16章 南亞市場分析

第17章 大洋洲市場

第18章 中東、非洲市場分析

第19章 市場結構分析

  • 依公司層級的市場分析
  • 主要公司市場佔有率分析
  • 市場現況分析

第20章 競爭分析

  • 競爭儀表板
  • 品牌與推廣策略
  • 主要發展分析
  • 競爭詳情
    • HiMedia Laboratories
    • HiMedia Laboratories
    • Speedy Assay Sdn Bhd
    • REAGEN LLC
    • FUJIKURA KASEI CO., LTD.
    • GeneReach Biotechnology Corp.
    • Thermo Fisher Scientific
    • Lab-Ind Resource Sdn Bhd.
    • SUREBIO
    • Auro Biotechnologies Pvt. Ltd.

第21章 使用的假設與縮寫

第22章 研究方法

簡介目錄
Product Code: PMRREP29626

Persistence Market Research has recently released a comprehensive report on the global Shrimp Disease Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • Shrimp Disease Diagnostics Market Size (2024E): US$500.9 million
  • Projected Market Value (2033F): US$821 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.6%

Shrimp Disease Diagnostics Market - Report Scope:

The Shrimp Disease Diagnostics Market focuses on the development and application of diagnostic tests for various diseases affecting shrimp, which are vital to aquaculture. The market encompasses various diagnostic methods, including molecular diagnostics, immunodiagnostics, and biochemical tests. Key growth drivers include the rising global demand for shrimp, increasing aquaculture activities, and the need for sustainable shrimp farming practices.

Market Growth Drivers:

Several key factors are driving the growth of the global Shrimp Disease Diagnostics Market. The increasing global demand for shrimp, fueled by rising consumption and exports, is a significant contributor. Furthermore, the need to maintain healthy shrimp populations to ensure productivity and profitability in aquaculture is pushing the adoption of diagnostic solutions. Increased awareness of disease management and prevention among shrimp farmers also supports market growth.

Market Restraints:

Despite its growth potential, the Shrimp Disease Diagnostics Market faces several challenges. High costs associated with advanced diagnostic technologies can limit their adoption, especially among small-scale farmers. Additionally, a lack of standardized testing protocols and limited awareness of available diagnostic solutions can hinder market expansion. Regulatory challenges and the varying prevalence of shrimp diseases across regions may also pose significant barriers.

Market Opportunities:

The Shrimp Disease Diagnostics Market presents substantial growth opportunities, particularly through advancements in technology. Innovations in molecular diagnostics, such as PCR-based tests, are expected to enhance disease detection capabilities. Collaborations between diagnostic companies and aquaculture stakeholders can drive innovation and expand market reach. Furthermore, increasing investment in research and development to create cost-effective and user-friendly diagnostic tools presents further opportunities for growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Shrimp Disease Diagnostics Market?
  • Which regions are witnessing the highest adoption of shrimp disease diagnostics, and what trends are influencing this growth?
  • How are advancements in diagnostic technologies impacting the competitive landscape?
  • Who are the leading players in the Shrimp Disease Diagnostics Market, and what strategies are they implementing to maintain their market positions?
  • What are the emerging trends and future prospects in the global Shrimp Disease Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Shrimp Disease Diagnostics Market, including companies like IDEXX Laboratories, Neogen Corporation, and Thermo Fisher Scientific, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic solutions and enhancing their distribution networks. Collaborations with aquaculture stakeholders, research institutions, and regulatory bodies are crucial for market penetration and sustained growth. Ensuring compliance with global regulatory standards and addressing the unique needs of shrimp farmers will help these companies maintain a competitive edge and achieve long-term success in the Shrimp Disease Diagnostics Market.

Key Companies Profiled:

  • HiMedia Laboratories
  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • REAGEN LLC
  • FUJIKURA KASEI CO., LTD.
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab - Ind Resource Sdn Bhd.
  • SUREBIO
  • Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

  • Rapid Testing Kits
  • Assay Based Kits

Disease:

  • WSSV (White Spot Syndrome Virus)
  • TSV (Taura Syndrome Virus)
  • YHV/GAV (Yellow Head/Gill Associated Virus)
  • IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • HPV (Hepatopancreatic Parvovirus)
  • MBV (Monodon Baculovirus)
  • IMNV (Infectious Myonecrosis Virus)
  • NHP-B (Necrotising Hepatopancreatitis Bacteria)
  • MoV (Mourilyan Virus)
  • Early Mortality Syndrome (EMS)

End User:

  • Fisheries
  • Aquaculture Laboratories
  • Marine Laboratories
  • Education and Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Recent Product Approvals
  • 4.3. Regulatory Landscape
  • 4.4. Reimbursement Scenario
  • 4.5. Supply Chain Analysis
  • 4.6. Porter's Analysis
  • 4.7. PESTLE Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Animal Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Healthcare Expenditure
    • 5.2.2. Historic and Current Revenue of Key Players
    • 5.2.3. Increasing Adoption of Diagnostic Tools
    • 5.2.4. Rising Incidences of Infectious Diseases
    • 5.2.5. Introduction of New and Advance Reagent Kits and Devices
    • 5.2.6. High Cost of Diagnostic kits
    • 5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
    • 5.2.8. Strategic Collaboration Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Reagent Kits
    • 6.1.2. By Disease
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Reagent Kits

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024-2033
    • 8.3.1. Rapid Testing Kits
    • 8.3.2. Assay Based Kits
  • 8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. WSSV (White Spot Syndrome Virus)
    • 9.3.2. TSV (Taura Syndrome Virus)
    • 9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
    • 9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
    • 9.3.5. HPV (Hepatopancreatic Parvovirus)
    • 9.3.6. MBV (Monodon Baculovirus)
    • 9.3.7. IMNV (Infectious Myonecrosis Virus)
    • 9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
    • 9.3.9. MoV (Mourilyan Virus)
    • 9.3.10. Early Mortality Syndrome (EMS)
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 10.3.1. Fisheries
    • 10.3.2. Aquaculture Laboratories
    • 10.3.3. Marine Laboratories
    • 10.3.4. Education and Research Institutes
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East & Africa
  • 11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Reagent Kits
    • 12.3.3. By Disease
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Reagent Kits
    • 12.4.3. By Disease
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Reagent Kits
        • 12.8.1.2.2. By Disease
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Reagent Kits
        • 12.8.2.2.2. By Disease
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Reagent Kits
    • 13.3.3. By Disease
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Reagent Kits
    • 13.4.3. By Disease
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Reagent Kits
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By End User
    • 13.8.2. Brazil Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Reagent Kits
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By End User
    • 13.8.3. Argentina Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Reagent Kits
        • 13.8.3.2.2. By Disease
        • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Reagent Kits
    • 14.3.3. By Disease
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Reagent Kits
    • 14.4.3. By Disease
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Reagent Kits
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By End User
    • 14.8.2. Italy Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Reagent Kits
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By End User
    • 14.8.3. France Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Reagent Kits
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By End User
    • 14.8.4. U.K. Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Reagent Kits
        • 14.8.4.2.2. By Disease
        • 14.8.4.2.3. By End User
    • 14.8.5. Spain Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Reagent Kits
        • 14.8.5.2.2. By Disease
        • 14.8.5.2.3. By End User
    • 14.8.6. BENELUX Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Reagent Kits
        • 14.8.6.2.2. By Disease
        • 14.8.6.2.3. By End User
    • 14.8.7. Russia Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Reagent Kits
        • 14.8.7.2.2. By Disease
        • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Reagent Kits
    • 15.3.3. By Disease
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Reagent Kits
    • 15.4.3. By Disease
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Reagent Kits
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By End User
    • 15.8.2. Japan Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Reagent Kits
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By End User
    • 15.8.3. South Korea Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Reagent Kits
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Reagent Kits
    • 16.3.3. By Disease
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Reagent Kits
    • 16.4.2. By Disease
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Reagent Kits
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By End User
    • 16.8.2. Indonesia Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Reagent Kits
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By End User
    • 16.8.3. Malaysia Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Reagent Kits
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By End User
    • 16.8.4. Thailand Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Reagent Kits
        • 16.8.4.2.2. By Disease
        • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Reagent Kits
    • 17.3.3. By Disease
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Reagent Kits
    • 17.4.2. By Disease
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Reagent Kits
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By End User
    • 17.8.2. New Zealand Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Reagent Kits
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Reagent Kits
    • 18.3.3. By Disease
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Reagent Kits
    • 18.4.3. By Disease
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Reagent Kits
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By End User
    • 18.8.2. Turkiye Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Reagent Kits
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By End User
    • 18.8.3. South Africa Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Reagent Kits
        • 18.8.3.2.2. By Disease
        • 18.8.3.2.3. By End User
    • 18.8.4. North Africa Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Reagent Kits
        • 18.8.4.2.2. By Disease
        • 18.8.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Branding and Promotional Strategies
  • 20.3. Key Development Analysis
  • 20.4. Competition Deep Dive
    • 20.4.1. HiMedia Laboratories
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Sales Footprint
      • 20.4.1.4. Key Financials
      • 20.4.1.5. SWOT Analysis
      • 20.4.1.6. Strategy Overview
        • 20.4.1.6.1. Marketing Strategy
        • 20.4.1.6.2. Product Strategy
        • 20.4.1.6.3. Channel Strategy
    • 20.4.2. HiMedia Laboratories
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Sales Footprint
      • 20.4.2.4. Key Financials
      • 20.4.2.5. SWOT Analysis
      • 20.4.2.6. Strategy Overview
        • 20.4.2.6.1. Marketing Strategy
        • 20.4.2.6.2. Product Strategy
        • 20.4.2.6.3. Channel Strategy
    • 20.4.3. Speedy Assay Sdn Bhd
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Sales Footprint
      • 20.4.3.4. Key Financials
      • 20.4.3.5. SWOT Analysis
      • 20.4.3.6. Strategy Overview
        • 20.4.3.6.1. Marketing Strategy
        • 20.4.3.6.2. Product Strategy
        • 20.4.3.6.3. Channel Strategy
    • 20.4.4. REAGEN LLC
      • 20.4.4.1. Overview
      • 20.4.4.2. Product Portfolio
      • 20.4.4.3. Sales Footprint
      • 20.4.4.4. Key Financials
      • 20.4.4.5. SWOT Analysis
      • 20.4.4.6. Strategy Overview
        • 20.4.4.6.1. Marketing Strategy
        • 20.4.4.6.2. Product Strategy
        • 20.4.4.6.3. Channel Strategy
    • 20.4.5. FUJIKURA KASEI CO., LTD.
      • 20.4.5.1. Overview
      • 20.4.5.2. Product Portfolio
      • 20.4.5.3. Sales Footprint
      • 20.4.5.4. Key Financials
      • 20.4.5.5. SWOT Analysis
      • 20.4.5.6. Strategy Overview
        • 20.4.5.6.1. Marketing Strategy
        • 20.4.5.6.2. Product Strategy
        • 20.4.5.6.3. Channel Strategy
    • 20.4.6. GeneReach Biotechnology Corp.
      • 20.4.6.1. Overview
      • 20.4.6.2. Product Portfolio
      • 20.4.6.3. Sales Footprint
      • 20.4.6.4. Key Financials
      • 20.4.6.5. SWOT Analysis
      • 20.4.6.6. Strategy Overview
        • 20.4.6.6.1. Marketing Strategy
        • 20.4.6.6.2. Product Strategy
        • 20.4.6.6.3. Channel Strategy
    • 20.4.7. Thermo Fisher Scientific
      • 20.4.7.1. Overview
      • 20.4.7.2. Product Portfolio
      • 20.4.7.3. Sales Footprint
      • 20.4.7.4. Key Financials
      • 20.4.7.5. SWOT Analysis
      • 20.4.7.6. Strategy Overview
        • 20.4.7.6.1. Marketing Strategy
        • 20.4.7.6.2. Product Strategy
        • 20.4.7.6.3. Channel Strategy
    • 20.4.8. Lab - Ind Resource Sdn Bhd.
      • 20.4.8.1. Overview
      • 20.4.8.2. Product Portfolio
      • 20.4.8.3. Sales Footprint
      • 20.4.8.4. Key Financials
      • 20.4.8.5. SWOT Analysis
      • 20.4.8.6. Strategy Overview
        • 20.4.8.6.1. Marketing Strategy
        • 20.4.8.6.2. Product Strategy
        • 20.4.8.6.3. Channel Strategy
    • 20.4.9. SUREBIO
      • 20.4.9.1. Overview
      • 20.4.9.2. Product Portfolio
      • 20.4.9.3. Sales Footprint
      • 20.4.9.4. Key Financials
      • 20.4.9.5. SWOT Analysis
      • 20.4.9.6. Strategy Overview
        • 20.4.9.6.1. Marketing Strategy
        • 20.4.9.6.2. Product Strategy
        • 20.4.9.6.3. Channel Strategy
    • 20.4.10. Auro Biotechnologies Pvt. Ltd.
      • 20.4.10.1. Overview
      • 20.4.10.2. Product Portfolio
      • 20.4.10.3. Sales Footprint
      • 20.4.10.4. Key Financials
      • 20.4.10.5. SWOT Analysis
      • 20.4.10.6. Strategy Overview
        • 20.4.10.6.1. Marketing Strategy
        • 20.4.10.6.2. Product Strategy
        • 20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology